A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors

NCT03355066 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

82

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated due business reasons by Sponsor.

Conditions

Solid Tumor, Adult

Interventions

DRUG: SM08502

Sponsor

Biosplice Therapeutics, Inc.